Abstract | Antibodies are essential components of adaptive immunity. A typical antibody repertoire comprises an enormous diversity of antigen-binding specificities, which are generated by the genetic processes of recombination and mutation. Accumulating evidence suggests that the immune system can exploit additional strategies to diversify the repertoire of antigen specificities. These unconventional mechanisms exclusively target the antigen-binding sites of immunoglobulins and include the insertion of large amino acid sequences, post-translational modifications, conformational heterogeneity and use of nonprotein cofactor molecules. Here, we describe the different unconventional routes for diversification of antibody specificities. Furthermore, we highlight how the immune system has a much greater level of adaptability and plasticity than previously anticipated, which goes far beyond that encoded in the genome or generated by the acquisition of somatic mutations.
Antibodies are the major components of humoral adaptive immunity to pathogens. They are produced by plasma cells, which derive from B cells that express on their surface the membrane-bound form of the antibody, that is, the B cell receptor (BCR). Antibodies first appeared in evolution in cartilaginous fish more than 500 million years ago 1 . The prototypic antibody molecule IgG is a congregation of four polypeptide chains: two identical heavy (H) and two identical light (L) immunoglobulin chains. The amino-terminal regions of heavy and light chains are characterized by extensive variability in the amino acid sequence. Accordingly, these parts of the molecule are referred to as variable (V) regions and are responsible for recognition of the antigen (the structural organization of V regions is described in Box 1) . By contrast, the carboxy-terminal part of the immunoglobulin molecule, referred to as the constant (C) region, is less variable and differs only between distinct immunoglobulin classes and subclasses. This particular structural organization enables antibodies to bridge the process of molecular recognition of antigen with initiation of destructive, innate, immune mechanisms such as activation of the complement system, phagocytosis and degranulation 2 . Adaptive immunity relies on sophisticated genetic mechanisms to create the diversity of antibody V regions. These mechanisms take place during B cell development in the bone marrow and upon encounter of antigen in the periphery. Two distinct processes contribute to the genetic diversification of V regions: V, D (diversity) and J (joining) recombination and somatic hypermutation (Box 2). Theoretically, under physiological conditions, the human immune system can generate BCRs with 10 26 distinct sequences 3, 4 , an astronomical number that is far greater than the calculated number of all B cell clones that can be generated during the lifespan of a healthy human (estimated to be 4 × 10 14 ) 3 . The recent advent of technologies that enable high-throughput sequencing of the entire human B cell repertoire 5, 6 , as well as isolation and characterization of human monoclonal antibodies 7, 8 , has contributed to the identification and better characterization of some alternative or unconventional mechanisms that contribute to diversification of the antibody repertoire. For example, antibodies have been reported to integrate nonimmunoglobulin proteins as part of their binding sites and to use these proteins for specific binding to target antigens. In addition, novel antigen-binding specificities can be generated by post-translational modifications, extensive flexibility in the structural dynamics of the antigen-binding site or the use of nonprotein cofactor molecules for antigen recognition. Notably, some unconventional strategies of antibody diversification are frequently elicited in response to infections with highly mutable pathogens.
In this Review, we classify the different unconventional mechanisms for antibody diversification and describe the molecular basis and putative biological roles of each mechanism. Finally, we discuss the broader implications of these unconventional pathways of generating antibody diversity.
Unconventional antibody diversification
In addition to the conventional genetic mechanisms used to generate antibody diversity, the immune system uses several alternative strategies to broaden the antibody repertoire. Below, we group these strategies into four distinct categories based on the molecular mechanism involved: insertion of non-immunoglobulin sequences in the variable region; post-translational modification of the variable region; conformational heterogeneity of the antigen-binding site; and use of nonprotein cofactors for antigen recognition (metal ions or haem).
Non-immunoglobin V-region insertions
Recent studies have shown that sequences from nonimmunoglobulin genes can be inserted into the V regions of immunoglobulins. In addition, we discuss the insertion or deletion of short nucleotide sequences (known as 'indels') into V-region genes during somatic mutation.
Insertion of long amino acid sequences into V regions.
The infection of red blood cells with Plasmodium falciparum results in the expression of parasite-derived antigens on cellular surfaces. After screening hundreds of plasma samples from adults living in malaria-endemic regions in Kenya, Tan et al. 9 identified two donors with antibodies that have broad reactivity towards antigens from eight different isolates of P. falciparum displayed at the surface of the infected erythrocytes. B cells from these donors were immortalized, and the sequence of the broadly reactive antibodies was analysed. Surprisingly, it was found that the heavy-chain variable (V H ) domain of these antibodies contained a large non-immunoglobulin fragment from chromosome 19 between the V and DJ segments in the CDR 3H region 9 . This foreign segment encodes 98 amino acids of leukocyte-associated immunoglobulin-like receptor 1 (LAIR1), an immunoglobin superfamily inhibitory receptor that normally binds to collagen 10 . Elegant experiments showed that antibodies directly use LAIR1 protein for the recognition of malarial antigens 9 . Interestingly, LAIR1 incorporated in the V H region carries a substantial number of somatic mutations that ablate the binding to collagen but confer increased affinity for P. falciparum antigens. Mass spectrometry identified the target antigens for LAIR1 as belonging to members of the repetitive interspersed families of polypeptides (RIFIN) family -the largest family of P. falciparum antigens displayed on infected erythrocytes 9 . Furthermore, X-ray crystallography analyses 11 revealed that LAIR1 is well folded and is displayed on the tip of the V region in an appropriate configuration for interaction with antigen (Fig. 1a) .
In another study, the same team evaluated the frequency of broadly reactive anti-RIFIN antibodies by screening two large cohorts of individuals exposed to P. falciparum in Tanzania and Mali 12 . It was found that 5-10% of the individuals exposed to this malarial parasite expressed LAIR1-containing antibodies, whereas such antibodies were not detectable in cohorts of nonexposed European donors. Sequence analyses of cDNA and genomic DNA from B cell clones isolated from donors with LAIR1-containing antibodies demonstrated that the insertions of the LAIR1 sequence can occur not only between the V and DJ gene segments but occasionally between the V domain and the first constant domain (CH1) of the heavy immunoglobin chain 12 . This variability allows the B cell clone to produce an antibody through alternative splicing either without or with a functional LAIR1 protein insert in the elbow region, thus conferring the antibody with a second antigen-binding specificity. In addition, a B cell clone from another donor produced a LAIR1-containing camel-like antibody that lacked the V H and C H1 regions as well as the entire light chain.
Importantly, deep-sequencing analyses of healthy European donors revealed a higher than expected prevalence of memory B cells with sequence insertions of 100-1,000 nucleotides from other chromosomes in the elbow region 12 . This finding suggests that antibodies can use this unusual strategy for diversification of their specificities against other pathogens as well. The molecular mechanisms governing the interchromosomal DNA transposition in B cells, which lead to the insertion of entire proteins in or next to the antigen-binding site, are not yet well understood. One can hypothesize that insertion of LAIR1 into the V region of antibodies involves the same molecular machinery that is responsible for the diversification of immunoglobulin genes, that is, the recombination-activating genes (RAG1 and RAG2) and activation-induced cytidine deaminase (AID). Notably, malaria infection is associated with marked genomic instability and AID-mediated translocations between different chromosomes in B cells 13 . The increased frequency of chromosomal translocations may facilitate LAIR1 incorporation into the V regions of antibodies. The B cells expressing such antibodies might be further positively selected and sustained because the LAIR1 protein provides a selective advantage for the broad recognition of different strains of the pathogen.
Box 1 | Structural organization of the variable region of antibodies
The variable (v) region, or v fragment (Fv), of antibodies consists of two non-covalently linked immunoglobulin domains: the light-chain variable (v l ) and heavy-chain variable (v H ) domains. each v domain contains approximately 120-130 amino acids and has the prototypic immunoglobulin superfamily domain structure of two antiparallel β-sheets. The β-strands from the two different planes are connected by loops that usually lack secondary structure. A single disulfide bridge between conservative cysteine residues and multiple hydrophobic contacts are responsible for the maintenance of the fold of each v domain. The variability in amino acid sequence differs throughout the structure of the v domains. Thus, each domain has four relatively invariant parts, referred to as framework regions (FR1-FR4), and three regions characterized by great heterogeneity in the amino acid sequence, referred to as complementarity-determining regions (CDR1-CDR3). The CDRs overlap with three of the surface-exposed loops that connect β-strands at the tip of the v domains. The sequence variability among different CDR loops also differs, with the CDR H3 and CDR l3 loops being the most diverse regions of the v domain. moreover, the length of the CDR H3 loop markedly varies between different antibodies; lengths of CDR H3 ranging from 2 to >30 amino acids have been reported for human antibodies. Not surprisingly, this region plays a central role in the binding to antigens. The association of v l and v H brings in close proximity the CDR loops from the two immunoglobulin domains. The six CDR loops, along with some parts of the FR, comprise the antigen-binding site of the antibodies. The CDR3 regions of heavy and light v domains are localized at the centre of the antigen-binding site. In addition to their central role for binding to antigen, CDRs are focal points for the incorporation of mutations during the process of affinity maturation. Accordingly, these parts of the v regions carry most of the modifications responsible for the unconventional diversification of antibody specificity.
Elbow region
A region of immunoglobulin molecule situated between the variable domain and the first constant domain.
Activation-induced cytidine deaminase
(AiD). An enzyme responsible for the introduction of somatic mutations in variable regions and for a class switch of immunoglobulins.
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Indels: in-frame insertions and deletions. During affinity maturation, an unconventional mechanism of generation of diversity in the V genes of the BCR may take place: the in-frame insertions or deletions of nucleotide sequences (referred to as indels) in V genes (Fig. 1b) . The frequency, localization and mechanisms of indel formation have been investigated by deep-sequencing analysis of the V-region genes of human B cells. Indels were estimated to be present in approximately 2% of circulating B cells from healthy individuals 14 . The frequency of indels is considerably higher in memory B cell subsets than in naive B cells. The size of an in-frame insertion or deletion ranges from 3 to 33 nucleotides 14, 15 , but most V regions contain short indels. The insertion or deletion of nucleotide sequences is mediated by the same machinery that is responsible for the introduction of point mutations during the affinity maturation process 15 . Indeed, the expression of AID is required and sufficient for both in vivo and in vitro formation of indels 16 . Importantly, indels and their proximal regions can be further modified by point mutations introduced by AID. The indels are most frequently located in the antigen-binding sites of antibodies, predominantly in the complementaritydetermining region (CDR) loops CDR1 and CDR2 of the V regions of both heavy and light chains. This explains their potential for remodelling the binding specificity of antibodies 14, 16 . Indels can also be introduced in framework regions of the V domain, especially in the FR3 of the heavy chain 17 . Long insertions are more frequent in CDRs, whereas long deletions are mostly located in the framework regions 14 . This phenomenon may be due to the restricted size of CDRs that cannot tolerate long deletions. The presence of indels induces considerable reconfiguration of the CDR loops and/or surrounding regions, leading to a dramatic impact on the antigen-binding specificity, affinity and functional activity of antibodies 17, 18 . Indels may have an important contribution to antibody-mediated neutralization of pathogens with high antigenic heterogeneity. Indeed, the frequency of insertions in V genes of B cells from individuals infected with HIV-1 is significantly increased compared with that of B cells isolated from healthy humans 17 . An elevated frequency of insertions, however, was not demonstrated in the case of B cells from patients chronically infected with the Epstein-Barr virus and/or cytomegalovirus 17 . Notably, a considerable fraction (40%) of the most potent and broadly neutralizing antibodies (bNAbs) for HIV contains indels 17 . Insertions in HIV-1 bNAbs are directly involved in the establishment of contacts with antigens 19 . They also modulate the antigen-binding kinetics of bNAbs and endow antibodies with broad HIV-1 neutralization potential.
The importance of indels was elegantly demonstrated in the study of the influenza-neutralizing human monoclonal antibody 2D1 (reF.
18
). 2D1 contains an insertion of three amino acids in the region between FR3 and CDR H2. The deletion of the indel from the antibody led to a The diversity of antibody repertoires is principally generated by two genetic mechanisms that involve recombination and mutation of the immunoglobulin genes 4, 117, 118 . The junctional diversity considerably extends the heterogeneity of the v regions generated by the recombination process. The process overlaps temporally with vDJ recombination during the early phases of B cell development. upon recombination of gene segments, DNA-processing enzymes add or delete nucleotides at the 3ʹ and 5ʹ extremities of the v, D and J segments, thus introducing imprecise junctions. The enzyme terminal deoxynucleotidyltransferase is responsible for addition of so-called nontemplate-encoded nucleotides 4, 119 . moreover, the opening of hairpin structures of DNA at the ends of the joining fragments can result in the insertion of short palindromic nucleotide sequences.
The second mechanism of diversification of the sequences of the v regions is based on the introduction of point mutations throughout the v H and v l regions 120 . This process usually takes place in secondary lymphoid organs after contact of naive or memory B cells with antigens in the presence of antigen-specific helper T cells. The enzyme activation-induced cytidine deaminase (AID), which is unique to the B lymphocyte lineage, is responsible for the introduction of the point mutations 121 . The process of somatic hypermutation markedly extends the sequence heterogeneity of the rearranged variable regions. See figure. RAG, recombination-activating gene. 
Somatic mutations
NATuRe RevIewS | Immunology considerable decrease in binding affinity for haemagglutinin, in neutralization potency and in therapeutic activity in vivo. Structural analyses revealed that the presence of an insertion in 2D1 results in the reconfiguration of the paratope in such a way that there is removal of a steric hindrance between the CDR H2 and a loop from the haemagglutinin molecule 18 . Conversely, the indeldeleted variant acquired a canonical configuration of the CDR H1 that was not suitable for potent neutralization of the influenza virus.
In conclusion, although the formation of indels is not a frequent phenomenon, it brings an additional level of diversity to antibodies, thus enabling them to adapt to antigen surfaces that are difficult to be recognized by conventional antibodies. Especially in the case of infection with HIV-1, for which their frequency is remarkably increased, indels may enable the immune repertoires to accommodate virus antigenic variability.
Post-translational modifications
Post-translational modifications of proteins represent covalent conjugation of nonprotein groups to the polypeptide chains. These modifications modulate the functional activity and physicochemical properties of many intracellular and extracellular proteins. There are many diverse types of post-translational modification, the most prominent being glycosylation, phosphorylation, lipidation and sulfation. Immunoglobins, like any protein, are subjected to post-translational modifications. A typical modification is glycosylation of Asn297 on the heavy chain of the human IgG molecule. The N-glycans added to the C region have an important impact on the effector functions of antibodies (reviewed elsewhere 20 ). In addition to C region modification, a fraction of human antibodies can undergo post-translational changes that are localized in the V region and therefore might directly influence antigen binding. Thus, tyrosine O-sulfation in CDR H3 or glycosylation in a V region contributes to the diversification of antigen-binding specificities of antibodies by tailoring the chemistry and topology of the antigen-binding region (Fig. 2) . 
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For some human antibodies, sulfation critically shapes their binding specificity; one such example is provided by patient-derived anti-HIV-1 antibodies, as described below.
A group of HIV-1-specific antibodies recognize an epitope on the viral envelope protein complex that is displayed only upon interaction of viral gp120 with CD4 on host cells. Accordingly, these antibodies are referred to as CD4-induced (CD4i) antibodies. Characterization of CD4i monoclonal antibodies isolated from people infected with HIV-1 revealed a peculiar feature of some of these antibodies -they have a sulfotyrosine in their CDR H3 (reFs 23, 24 ). Most of the human CD4i antibodies are encoded by a restricted set of V-region genes belonging to the V H 1-69 and V H 1-24 families 23 . Usually, these antibodies have long CDR H3 loops that are rich in tyrosines interspersed between acidic amino acids, a preferential target pattern for tyrosylprotein sulfotransferases. The presence of tyrosine sulfation was demonstrated to be critical for binding to gp120 and for virus neutralization by some CD4i monoclonal antibodies. Thus, mutation of tyrosine to phenylalanine or silencing of tyrosylprotein sulfotransferases in antibody-expressing cells resulted in complete abrogation of gp120 binding and HIV-1 neutralization by the CD4i antibody 412d 23 . In general, antibodies containing sulfotyrosine neutralize HIV-1 more potently than antibodies directed to the same region on gp120 but lacking this post-translational modification.
Structural analyses of the CD4i monoclonal antibodies 47e, E51 and 412d demonstrated that sulfotyrosine residues are located on the tip of protruding and highly disordered CDR H3 loops 24 . The antigen-binding sites have a strong negative charge owing to the sulfate groups. Two of the investigated antibodies have a single sulfotyrosine, and one has two sulfotyrosine residues in CDR H3 (reF. 24 ). The binding site for gp120 on the HIV-1 coreceptor CC-chemokine receptor 5 (CCR5) overlaps with the epitope of CD4i antibodies. Notably, a region of CCR5 responsible for the binding of gp120 to CCR5 also contains a sulfotyrosine 25 . Indeed, a peptide from the CCR5 coreceptor, containing the sulfotyrosine, competes with the monoclonal antibodies for binding to the gp120-CD4 complex 23 . Structural analyses revealed that the sulfotyrosine residues of CCR5 and the CD4i antibody 412d adopt an almost identical configuration while binding to the same binding site on the gp120 molecule 26 . Thus, both sulfotyrosines are accommodated in a deep pocket with hydrophobic surroundings and cationic bases; the sulfate group of tyrosine establishes numerous non-covalent contacts with residues from the antigen. These results suggest that the presence of sulfotyrosines in the CDR H3 of CD4i antibodies confers a molecular mimicry whereby antibodies bind the virus in a manner analogous to the binding of the coreceptor molecule to the virus. Accordingly, the antibodies containing sulfotyrosines in their CDR H3 loops are efficient at neutralizing CCR5-tropic strains but fail to ). b | Fab glycosylation. A fraction of antibodies can carry an N-linked glycan structure bound to CDRs. The glycan structure is complex and often terminates with sialic acid. Antibodies can utilize the carbohydrate moieties as a part of an extended binding site, which enables establishment of specific interactions with an antigen. Blue, immunoglobulin heavy chain; grey , immunoglobulin light chain; red, side chains of sulfated tyrosines.
Epitope
The part of the antigen that is recognized by the paratope of an antibody, that is, the complementary part of the paratope.
NATuRe RevIewS | Immunology neutralize HIV-1 strains that use the CXC-chemokine receptor 4 (CXCR4) coreceptor for infection of cells 23 . Tyrosine sulfation has also been described in another class of HIV-1-neutralizing human antibodies. The epitopes of the antibodies 2909, PG9 and PG16 overlap with V2 and V3 loops on gp120. Structural analysis revealed that these antibodies contain sulfated tyrosines in their CDR H3 loops 27, 28 . Similarly to what was seen with CD4i antibodies, the removal of sulfotyrosine from strain-specific antibody 2909 by mutation to phenylalanine resulted in loss of its neutralization potential 28 . Moreover, the removal of sulfotyrosines from the bNAbs PG9 and PG16 significantly reduced their HIV-1-neutralization potency 27 .
In conclusion, some antibodies show sulfation of tyrosines in their hypervariable regions, and this posttranslational modification can help them to bind to and neutralize HIV-1. The unique chemical reactivity of the sulfate groups endows the antibodies with novel binding features. It is noteworthy that these results infer that the humoral immune response can produce antibodies that mimic recognition tactics used by other receptors.
N-glycosylation of the V region. In healthy humans, 15-25% of IgG antibodies have N-linked glycan structures in their V H or V L regions 29 . The frequency of antibodies with V-bound glycan structures can increase considerably in some pathological conditions, such as rheumatoid arthritis and Sjörgen syndrome [29] [30] [31] [32] . Interestingly, human antibody repertoires encoded by naive B cells are almost devoid of antigen-binding fragment (Fab)-bound glycans. The glycosylation sites are virtually absent from the germline sequences and are introduced in V-region genes predominantly as a consequence of the somatic hypermutation process 29, 33, 34 . The hot spots for mutations leading to glycosylation in V regions are predominantly located within the CDR loops or in a close proximity 34 . Analyses of Fab glycosylation of antibodies isolated from healthy donors revealed that the prevalence of N-glycosylation of the V regions differs among IgG subclasses. The most frequently glycosylated human IgG is the IgG4 subclass, with 44% of the molecules having N-linked glycans. Among the other subclasses, the N-glycosylation of the V region occurs for 11-15% of them. Notably, the frequency of V-glycosylated antibodies also depends on the target antigen and may change depending on the physiopathological state. Thus, a majority of autoantibodies (80-100%) recognizing citrullinated proteins in patients with rheumatoid arthritis contain Fab-bound glycans 31, 32, 34 The most frequent glycan structure attached to V regions is a complex biantennary type enriched in terminal 2,6-linked sialic acids. In contrast to the N-glycan attached to the Asn297 of the C region, V-region glycans are considerably more exposed on the surface of the IgG molecule 35, 36 . The predominant localization of N-glycosylation sites in the antigen-binding site and the high exposure of the glycan suggest that this posttranslational modification can influence the antigenbinding specificity of the antibodies. Indeed, a study of an antidextran monoclonal antibody, containing an N-glycan bound to the CDR H2, showed that removal of this post-translational modification leads to a 15-fold decrease in the binding affinity of the antibody 35 . A similar decrease in binding affinity was observed after specific removal of sialic acid from the V region of an IgG that was specific for the gonadotropin-releasing hormone 37 . Another study has shown that the human polyreactive antibody CBGA1 possesses complex N-glycans consisting of biantennary and tetra-antennary glycans. These glycans are rich in sialic acid (which constitutes approximately 18.2% of glycan composition) and consequently show an overall negative charge. Removal of the glycan of CBGA1 using specific inhibitors of the cellular glycosylation machinery resulted in an almost complete abrogation of binding to its target antigens -namely, tetanus toxoid, diphtheria toxoid and double-stranded DNA (dsDNA) 36 . This result points to an intriguing case in which a complex glycan structure attached to a V region mediates the antigen-binding polyreactivity of an antibody.
In a recent investigation, a panel of Fab-glycosylated human IgG monoclonal antibodies was mutated at the glycosylation sites back to the germline residues. In most IgGs, the mutations abrogating the glycosylation of the V region resulted in a significant decrease in the binding affinity for the target antigen 34 . Another study demonstrated that a human IgG alloantibody (LE2E9) that neutralizes the procoagulant activity of factor VIII (F8) has a complex glycan structure bound to CDR H1 (reF. 38 ). While the removal of the V-linked glycan by mutagenesis did not affect the antibody's binding affinity for factor VIII, it significantly decreased its neutralizing activity. Moreover, although the wild-type LE2E9 antibody efficiently blocked the binding of factor VIII to its chaperone -the von Willebrand factor -the aglycosylated LE2E9 antibody lost this activity. This finding suggests that the glycan in the LE2E9 antibody blocks the interaction of factor VIII with von Willebrand factor through steric hindrance 38 . These findings point to the importance of V-region glycans for modulating the functional activity of antibodies independently of the antigen-binding properties of the antibody.
Addition of N-glycans has also been used for the rational engineering of antibodies. Thus, the introduction of N-linked glycans to the binding site of an anti-CD4 humanized monoclonal IgG, ibalizumab, resulted in a dramatic augmentation of the breadth and potency of HIV-1 neutralization 39 . Of note, the introduction of glycan structures to the antigen-binding sites of antibodies with defined specificity has also been shown to decrease antigen-binding polyreactivity or to completely inhibit the interaction with target antigens 40, 41 . Collectively, these findings suggest that V-region-linked carbohydrates contribute to the diversification of the specificity of antibodies. The molecular mechanisms underlying the contribution of N-linked glycans to antigen binding are not elucidated to date. However, one can expect that carbohydrates enhance the chemical diversity of paratopes by providing numerous additional possibilities for noncovalent contacts and enriching the shape complexity. Moreover, the high degree of conformational dynamics that characterizes glycans may contribute to an extension of the repertoire of configurations of the antigen-binding sites, thus diversifying the binding specificities.
www.nature.com/nri
Conformational heterogeneity Every protein has a certain degree of conformational dynamics ranging from infinitesimal structural fluctuations, which are typical for rigid proteins, to global structural dynamics, which are characteristic of intrinsically disordered proteins 42, 43 . Likewise, the extensive heterogeneity of the amino acid sequences of V regions results in antibodies with different degrees of flexibility in their antigen-binding sites. As a result, a single antigenbinding site can acquire multiple configurations, thus resulting in binding to distinct antigens and diversification of antigen-binding specificity 44, 45 . In rare cases, antibodies have also been reported to reconfigure the global structure of the Fab, thus achieving unconventional recognition of carbohydrate antigens (discussed below).
Conformational dynamics of the V region.
The conformational flexibility of an antibody plays a key role in recognition of its cognate antigen. Antibodies with pliable antigen-binding sites are capable of binding to many structurally unrelated antigens [46] [47] [48] [49] and are defined as polyreactive, polyspecific or promiscuous. Antibodies with highly flexible binding sites can exploit larger conformational space, thus adapting to molecular features of different targets. Hence, one sequence of a V region with its plurality of configurations can accommodate numerous different antigens. This flexibility can lead to an enormous broadening of the array of antigenic targets potentially recognized by the humoral immune repertoire.
Different structural and biophysical analyses demonstrated that antibodies with V regions encoded by germline sequences exhibit a generally higher degree of conformational dynamics in their antigen-binding sites 46, [50] [51] [52] [53] [54] [55] [56] . These studies, however, have limitations, as they usually only encompass a small number of antibodies that target (except in the study of Schmidt et al. 56 ) compounds of low molecular mass (haptens), peptides or carbohydrates. A recent computational study comprehensively analysed the molecular dynamics of the flexibility of the CDR H3 as a function of affinity maturation for thousands of human antibody sequences. The results revealed that there is no straightforward correlation between the degree of molecular flexibility and the level of somatic mutations introduced in the V regions. Thus, the accumulation of somatic mutations may result either in the rigidification or, to the contrary, an increase in the structural dynamics of the CDR H3 (reF.
57
). This finding was further confirmed by an investigation focused on the effect of affinity maturation on the flexibility of the antigen-binding site of different HIV-1 bNAbs 58 and by the observation that affinity maturation resulted in an increase in the plasticity of an antibody targeting a hen egg lysozyme 59 . The diversification of binding specificities through conformational dynamics may be important for antibodies that target highly heterogeneous pathogens, such as HIV-1. Binding analyses demonstrated that many bNAbs are highly promiscuous and recognize many unrelated antigens apart from the HIV-1 Env proteins 8, [60] [61] [62] . It is noteworthy that these antibodies are often characterized by high numbers of somatic mutations. Recent results suggested that enhanced structural dynamics might directly contribute to the accommodation of antigenic variability and neutralization of distinct strains of HIV-1 (reF. 63 ). In addition, in the case of two monoclonal bNAbs, 3BNC60 and 3BNC117, accumulation of a large number of somatic mutations that affect the framework regions results in acquisition of a prominent molecular flexibility in the V H β-sheet framework region. This extraordinary flexibility directly contributes to the binding to highly heterogeneous epitopes on gp120 of distinct HIV-1 strains 19 , resulting in potent and broad neutralization of the virus.
Two structural models of molecular dynamics account for the binding promiscuity of antibodies 44, 64 . The 'induced-fit' model (also known as the Koshland model), which was initially developed to describe enzyme-substrate interactions, stipulates that structural changes in the antigen-binding site that take place during the molecular-recognition process result in adaptation to the target molecule 65 . This model assumes that a higher level of pliability of the V region enables adaptation to a larger set of unrelated antigens. As a large range of conformational adaptations commonly occurs in all antibody-antigen interactions, the induced-fit model is not an unconventional strategy for diversification of antibody specificities per se. Alternatively, the conformational-selection model proposes that, in the absence of antigen, the antigen-binding sites of a given antibody concomitantly exist in distinct configurations (isomers) (Fig. 3a) . Each isomer has the capacity to recognize different molecular targets. Depending on the available antigen, a given isomer will be preferentially engaged 65 . Kinetic and structural evidence has been provided for the existence of this unconventional mechanism of diversification of antibody specificities 66, 67 . For instance, structural analyses of the mouse monoclonal IgE clone SPE7 demonstrated a dramatic and diverse reconfiguration of the antigen-binding site in the absence of antigen 68 . In one of the configurations, the binding site of SPE7 forms a deep and narrow pocket, which is appropriate for the recognition of haptens. Another configuration of SPE7 forms a large, flatshaped, antigen-binding site, which is suitable for the recognition of protein antigens (Fig. 3a) . Notably, kinetic studies of SPE7 revealed that the binding promiscuity of this antibody is driven by the simultaneous implication of induced-fit and conformational isomerism 67, 68 . More than 20% of B cells from healthy individuals express BCRs with prominent antigen-binding polyreactivity 48, [69] [70] [71] [72] . This frequency may be further increased upon some viral or bacterial infections 62, [73] [74] [75] [76] . The proportion of polyreactive antibodies that use conformational isomerism for diversification of their antigen-binding specificities remains unknown. However, it is highly probable that this mechanism represents a predominant way for achievement of binding promiscuity of antibodies, as has been shown for other proteins 65, 77 .
Global reconfiguration of Fab. Another unorthodox strategy to achieve diversification (Fig. 3b) of the antigenbinding specificity of antibodies, which is based on structural changes in the molecule, is exploited by a human HIV-1 bNAb called 2G12 (reF.
78
). This antibody NATuRe RevIewS | Immunology recognizes mannose residues displayed on the dense glycan cluster on the surface of gp120. The structural analyses of 2G12 revealed an unconventional configuration of its antigen-binding site. Thus, the V H domains of the antibody are swapped, leading to their direct contact. This dramatic structural reconfiguration results in formation of an extended binding surface consisting of V L -V H -V H -V L domains (instead of what is seen in classical antibodies). The binding surface exhibits four antigen-binding sites -two primary sites and two sites that are formed as a consequence of V H domain swapping. The structural reconfiguration of 2G12 is due to a number of somatic mutations that curtail the noncovalent interactions that generally hold V H -V L together, modify the elbow between V H and C H1 and introduce complementarity throughout the V H -V H surface 78 . This unique architecture enables 2G12 to recognize a cluster of dense oligomannose carbohydrates on gp120 with an affinity in the nM range 79 . In the case of the canonical antigen-binding site of immunoglobins, such recognition is prohibited owing to steric constraints.
The binding site of 2G12 on gp120 overlaps with binding sites of other HIV-1 bNAbs (PGT121 and 10-1074 families). However, these antibodies use conventional mechanisms for antigen recognition. The difference between 2G12 and other antibodies targeting the same neutralization site on gp120 is that the latter contact both the protein and carbohydrate components of gp120 (reF. 80 ), whereas the epitope of 2G12 consists only of glycan. It is tempting to speculate that the selective pressure for high-avidity recognition of the glycan epitope on gp120 resulted in an untypical organization of the binding site of 2G12.
A recent study revealed yet another stratagem that increases the avidity for repetitive epitopes on pathogens 81 . Antibodies targeting the circumsporozoite protein (CS; anti-NANP antibodies) of P. falciparum can provide protection against malaria infection. Interestingly, it was demonstrated that some anti-NANP human antibodies acquire a set of somatic mutations that facilitate the self ('homotypic') association of two V regions during the recognition of the antigen 81 . Such a homotypic binding of V regions contributes to augmentation in binding avidity, thus resulting in efficient recognition of repetitive epitopes of the antigen. At the level of the BCR, the homotypic interaction of different 
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receptors that is induced by the circumsporozoite antigen results in potent B cell activation 81 . In contrast to the mechanism used by 2G12, the V regions of anti-NANP antibodies that associate together and create a peculiar antigen-binding surface belong to distinct antibody molecules.
Use of nonprotein cofactors
Many prokaryotic and eukaryotic proteins use different cofactors, ranging from metal ions to large organic compounds, to extend their functional activities. For example, cofactors enable enzymes to catalyse multifarious types of reactions, which would be impossible with the mere use of amino acids from the polypeptide chain. Interestingly, some antibodies have been reported to exploit nonprotein cofactors for the diversification of their antigen-binding specificities (Fig. 4) . This part of the Review focuses on the inherent tendency of some antibodies to use this diversification tactic. . Q425 demonstrated high selectivity for Ca 2+ , because other bivalent metal ions had only minimal or no effect on its binding to CD4. Structural analyses of Q425 indicate that the structure of its antigen-binding site (or its overall structure) is not affected by the absence or presence of Ca
2+
. The Ca 2+ ion occupies a central position in the antigen-binding site and interacts with the side chains of amino acids Asn32a, Asp32 and Glu50 from the CDR H3, CDR L1 and CDR L2, respectively, and with a backbone carbonyl of Ser91 from the CDR L3. The Ca 2+ ion is displayed at the surface of Q425 in such a manner that it enables the establishment of metal coordination bonds with amino acids of the target antigen 82 . Thus, Ca 2+ in Q425 is used as an interfacial cofactor that bridges the antibody to the antigen.
Another case of metal-dependent antigen recognition is described for the humanized sphingosine 1-phosphate-specific IgG LT1009 (reF. 83 ). LT1009 was developed as a potential therapeutic antibody for neoplastic diseases and macular degeneration. Structural analyses of the complex of LT1009 with its antigen revealed that the antibody uses two Ca 2+ ions as a bridge between its paratope and sphingosine 1-phosphate 83 . Both Ca 2+ ions are bound in close proximity to each other by side chains of aspartic acids from the CDR L1 and CDR L3 loops. The Ca 2+ ions directly interact with the phosphate group from sphingosine 1-phosphate. The interaction between LT1009 and its antigen was 124 and can mediate considerable diversification of the antigenbinding specificities of the antibodies. The 3D structure of the haem-binding antibody (Ab21) was modelled by the sequence-based V-region modelling algorithm RosettaAntibody3 (reF.
125
) implemented on the ROSIE web server. The putative haem-binding site was then predicted by docking the protoporphyrin IX molecule to the V region using the SwissDock web service based on EADock DSS completely abrogated in the presence of chelating agents or after replacement of either of the Ca 2+ -binding aspartic acids with an alanine 83 . These experiments highlight the critical role played by Ca 2+ ions as cofactors in the determination of the antigen specificity of some antibodies. It is noteworthy that both Q425 and LT1009 exhibit high levels of homology, with differences in the positions of the Ca 2+ -binding residues. The anti-human protein C antibody HPC4 is another antibody that gains specificity for its target antigen only in the presence of Ca 2+ ions. In this case, the Ca 2+ ions were proposed to bind to the antigen-binding site of the antibody 84 , but it was not demonstrated whether, similarly to Q425 and LT1009, HPC4 uses the metal ions as an interfacial cofactor for interacting with its cognate antigen. Other investigations demonstrated that exposure of pooled human IgG obtained from plasma of more than 3,000 healthy donors (intravenous immunoglobulin (IVIG)) to Fe 2+ ions results in a considerable broadening of the repertoire of recognized antigens. Interestingly, the diversification of antigenic specificities was not observed in the presence of other transition metal ions 85 . Whether Fe 2+ ions directly contribute to antigen binding (as is the case with Ca 2+ ions) or instead induce structural changes in the V regions of some IgGs, however, was not deciphered.
Use of haem.
Early studies on the distribution of essential enzyme cofactors in healthy human plasma indicated that the γ-globulin fraction binds to significant amounts of riboflavin, thiamine and nicotinic acid, which are essential cofactors for numerous enzymes 86 . Further studies demonstrated that human pooled immunoglobins bind to the riboflavin-containing cofactors flavin mononucleotide (FMN) and FAD with higher affinity than albumin, which is a known transporter of aromatic compounds in plasma [87] [88] [89] . Antibodies isolated from patients with myeloma have also been shown to bind to riboflavin with high affinity 90 , and the crystal structure of one such antibody-riboflavin complex has been resolved 91 . Circulating immunoglobins have also been reported to interact with ATP 92 , and high frequencies of human antibodies inherently binding to xenobiotic aromatic substances (nitrophenols) have been reported since the pioneering immunochemistry works on immunoglobins 49, 93, 94 . Haem (iron protoporphyrin IX) has also been shown to interact with circulating antibodies 95 , and there is compelling evidence that it can diversify the antigenbinding specificities of these antibodies. Haem is an essential heterocyclic compound that acts as a prosthetic group in many proteins. Under homeostatic conditions, haem is bound to haemoproteins (haemoglobin, myoglobin, cytochromes and many others) and is sequestered intracellularly. However, haem can be released extracellularly during various pathological conditions associated with haemolysis, such as malaria, sickle cell disease, rhabdomyolysis, ischaemia-reperfusion injury, autoimmune diseases and sepsis 96, 97 . Free haem is a very reactive molecule and has profound effects on different plasma proteins including immunoglobins 98 . Studies by McIntyre and colleagues showed that incubation of whole human blood or plasma with haem-containing medium results in the appearance of considerable antibody reactivity against different phospholipids 99 . Likewise, exposure of purified, pooled, human IgG to haem leads to the acquisition of considerable reactivity to many prototypical autoantigens used as targets for the diagnosis of autoimmune diseases [100] [101] [102] . Further investigations revealed that the interaction of human antibodies with haem induces a diversification in reactivity not only towards autoantigens but also towards pathogen-derived antigens 95, 103, 104 . It is noteworthy that the binding affinities for the antigens recognized by haem-exposed IgG are substantial 105 . Binding analyses of repertoires of human monoclonal antibodies revealed that, depending on the studied antigen, the fraction of IgG that acquires novel antigen-binding specificities after contact with haem ranges between 9% and 24% 103, 104 . Of note, the repertoire analyses demonstrated that haem-sensitive IgG had a significantly lower number of somatic mutations in the genes encoding its V regions than the IgG that did not change its specificity upon exposure to haem 103, 104 . Further studies demonstrated that the haem-induced acquisition of novel antigen-binding specificities is due to a direct binding of haem to antibodies. The most probable interaction site of haem is in the V region in proximity to or overlapping with the antigen-combining site 105, 106 . Once bound to the antigen-binding site, haem might be used as an interfacial cofactor for engagement with the antigen 95, 106 (Fig. 4b) . The diversification of antigen-binding specificities of normal IgG by haem could be explained by the peculiar features of the latter. Indeed, the unique physicochemical characteristics of haem, the presence of aromatic, hydrophobic, metal coordinating and anionic groups, offer an enormous diversity of possible variants of non-covalent contacts 107 prone to enrich the physicochemical heterogeneity of the antigen-combining sites and enhance the overall tendency of antibodies to interact with proteins for which they are not initially specific.
The biological significance of the broadening of the antigen-binding diversity of antibody repertoires by haem remains unclear. Efforts have focused on determining the therapeutic effect of antibodies pretreated in vitro with haem and then administered in models of inflammatory and autoimmune diseases. For example, in contrast to mice injected with native, pooled IgG, mice treated with a single dose of IgG exposed to haem were better protected from lipopolysaccharide-induced systemic inflammation 108 . A beneficial role of haembound IgG has also been demonstrated in a model of autoimmune diabetes 109 ; that is, the protective effect of haem-exposed IgG was associated with a decrease in the circulating levels of pro-inflammatory cytokines and in the infiltration of cytotoxic T cells in pancreatic islets. Taken together, these results suggest that haem-induced diversification of the antigen-binding specificity of IgG may have systemic and nonspecific immunomodulatory effects in situations associated with liberation of extracellular haem.
In conclusion, certain antibodies can bind to compounds of low molecular mass (Ca 2+ ions or haem) and use these compounds as interfacial cofactors for γ-Globulin fraction A fraction of human serum that consists mainly of immunoglobulins.
www.nature.com/nri recognition of diverse antigens. The cofactors enrich the reactivity of the binding interface, thus allowing recognition of a larger set of target antigens.
Relevance of unconventional diversification
In the preceding sections, we have presented evidence for the existence of unconventional strategies that broaden the antibody repertoire. These mechanisms are either based on the intrinsic structural hetero geneity of the paratope or involve covalent or non-covalent chemical modifications of the antigen-binding region. The use of these unconventional diversification strategies is not independent from that of conventional diversification mechanisms. Instead, in most cases, classical mechanisms predetermine the engagement of alternative strategies. Thus, somatic mutations introduced in V-region genes can result in unique sequence motifs that are specific targets for enzymes adding glycans or sulfate groups to asparagine or tyrosine residues, respectively. In addition, the increased structural diversity of antigenbinding sites might be predetermined by the elevated number of particular amino acids at specific locations in the V regions or by the presence of long CDRs. For example, polypeptide sequences rich in glycine residues possess high, intrinsic, conformational dynamics 110, 111 . Similarly, the dramatic reconfiguration of the binding site of the HIV-1-neutralizing antibody 2G12 results from somatic mutations that weaken contacts in the V H -V L interface and others that strengthen contacts in the V H -V H interface 78 . Taken together, these results strongly suggest that, with the possible exception of the incorporation of large non-immunoglobulin protein sequences in immunoglobin V regions 9, 12 , the same evolutionary principles of mutation and selection responsible for the diversification of antibody repertoires govern the diversification of antigen-binding specificities by unconventional strategies.
A prominent feature of these unconventional pathways for expanding the antigen-binding diversity of antibodies is that these pathways are frequently implicated in the recognition of pathogens with high antigenic variability, such as HIV-1, influenza virus and Plasmodium sp. This fact implies that the immune system recruits alternative strategies of generating diversity in order to compensate for the rapid pace of changes of certain target pathogens. We propose that the structural restrictions of the canonical topology of the V region impose limits on the ability of antibodies to encompass the breadth of possible target epitopes. Incorporation of uncommon chemical groups (such as carbohydrates, sulfates, haem or metal ions), use of proteins or reconfiguration of the topology of the antigen-combining sites by conformational isomerism might all compensate for the structural hurdles imposed by different antigens.
The existence of different unorthodox mechanisms for the generation of antigen-binding diversity clearly demonstrates that the adaptive immune response is characterized by extraordinary adaptability. Thus, boundaries defining the limits of repertoire diversity can fluctuate and be crossed when the system cannot efficiently cope with pathogens (Fig. 5) . Most probably, the continuous persistence of highly variable pathogens is the essential trigger for launching some of the nonstandard diversification pathways. The unconventional pathways for diversification of antibody specificities are used only as a last resort, possibly as a result of their expense in terms of energy resources and risk of unwanted reactivities, in particular, by overcoming immune-tolerance checkpoints. For example, large rearrangements of the genome of B cells in patients with malaria that result in the incorporation of nonimmunoglobin proteins in the V regions of antibodies may represent a substantial risk of the malignant transformation of B cells. In this respect, an elevated prevalence of B cell lymphoma has been reported in people with malaria 13 . Likewise, antibodies with binding sites Three levels of generation of antigen-binding diversity in immune repertoires with respect to the theoretical set of all potential antigenic structures that the immune system can encounter (referred to as 'antigen space'). The variability of antibodies generated by combinatorial and junctional diversity is limited and covers a small area of the antigen space. The resulting repertoire of binding specificities is nevertheless sufficient to control a substantial array of pathogens by thymus-independent B cell responses. Somatic hypermutations represent the second level of introduction of antibody diversity that occurs at the time of affinity maturation during thymusdependent immune responses. The variability in antigenbinding specificity acquired by this process is sufficient for controlling most pathogens. The third level of diversification of antibody specificities implicates additional unorthodox strategies for remodelling variable (V) regions. These processes considerably extend the coverage of the antigen space. In particular, unorthodox, or unconventional, pathways for diversifications are typically summoned in cases of infections with pathogens with high antigen variability. We propose that the evolutionary pressure exerted by an ever-mutating pathogen on the immune system dictates the engagement of unconventional mechanisms for a further expansion of the array of antigenbinding specificities. Whether a synergy between the three levels of diversification is sufficient to cover entire antigen space remains unclear.
existing in different structural conformers may have potentially pathogenic levels of binding polyreactivity and autoreactivity; such antibodies will presumably be characterized by a short circulatory half-life 112 . The unconventional post-translational diversification of antigen-binding specificities might also be triggered in cases of dramatic changes in the microenvironment. Thus, severe tissue damage or haemolysis may result in the release of haem into the extracellular space, which would bind to some of the circulating antibodies and induce the appearance of new antigen specificities. One can speculate that the recruitment of novel antigenbinding specificities in such situations contributes to antibody-mediated clearance of dead cells or neutralization of endogenous pro-inflammatory mediators, such as HMGB2, histones and cytokines.
With the advent of high-throughput technologies for the sequencing and analysis of vast human immunoglobin repertoires, one may anticipate the discovery of additional mechanisms for diversification of immune specificities. Thus, additional types of post-translational modification might be described to contribute to the chemical variability of the antigen-combining sites. Moreover, cofactors other than Ca 2+ ions and haem may also be recruited by antibodies for modulating their specificities. Notably, although at very low frequency, some human immunoglobins possess cysteine residues in their CDR3 loops 113, 114 ; the presence of this residue would provide a surface-exposed sulfhydryl group that under oxidative conditions could serve as a tag for binding via formation of disulfide bonds with other sulfhydryl-group-containing compounds (glutathione, homocysteine or coenzyme A) or even entire proteins to V regions of antibodies. These modifications would have a dramatic impact on binding specificity. In addition to high-throughput sequencing, mass spectrometry analyses of large antibody repertoires would contribute to the identification, at the protein level, of new types of modification of antibodies and concomitantly of novel pathways for diversification of antigen-binding specificity.
All strategies for unorthodox diversification of antibody specificities described in the present Review have been illustrated in the case of human or mouse antibodies. It is unknown at what stage in phylogeny these mechanisms first appeared. One can speculate that the emergence of somatic mutagenesis is the pivotal moment for all mechanisms except for conformational heterogeneity. It is noteworthy that antibodies with untypical configurations of V regions, such as single V-domain antibodies (present in sharks and camelids) 115 or abnormally enlarged CDR H3 (present in cattle) 116 , have been reported. Consequently, studies of antibody repertoires in different species can reveal yet other unorthodox tactics for generation of antibody diversity.
Antibodies might also use different unconventional strategies simultaneously for diversification of their binding specificities. For example, there is a high probability for indel-containing antibodies to be glycosylated or sulfated. Antibodies with high degrees of structural heterogeneity may simultaneously have posttranslational modifications in their V domains. Indeed, structural analyses of HIV-1-neutralizing antibodies that carry sulfated tyrosines revealed that their CDR H3 loops are characterized by a high level of conformational flexibility 24 . We may expect synergy between different diversification mechanisms (conventional and/or unconventional) to generate an even higher degree of variable antigen-binding sites.
Conclusion
Here, we have described and classified different unconventional mechanisms for the diversification of antigen-binding specificities of antibodies. These processes testify to the spectacular adaptability of humoral immune responses. We propose that antibody-antigen binding diversity acquired by unorthodox mechanisms represents a third layer of diversification of immune repertoires beyond the variability introduced by (mere) recombination and mutagenesis (Fig. 5) . www.nature.com/nri
